Healthcare provider profile · identity verified

John T Kelley, MD

Internal Medicine · IOWA CITY, IA · NPI 1871567131

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	540	151
Hydrochlorothiazide	Hydrochlorothiazide	440	116
Levothyroxine Sodium	Levothyroxine Sodium	256	64
Losartan Potassium	Losartan Potassium	249	67
Simvastatin	Simvastatin	240	66
Lisinopril	Lisinopril	236	64
Amlodipine Besylate	Amlodipine Besylate	203	61
Omeprazole	Omeprazole	184	48
Allopurinol	Allopurinol	180	53
Metformin Hcl	Metformin Hcl	152	42
Metoprolol Succinate	Metoprolol Succinate	150	46
Tamsulosin Hcl	Tamsulosin Hcl	140	42
Eliquis	Apixaban	117	21
Rosuvastatin Calcium	Rosuvastatin Calcium	111	32
Escitalopram Oxalate	Escitalopram Oxalate	104	27
Pantoprazole Sodium	Pantoprazole Sodium	104	27
Potassium Chloride	Potassium Chloride	87	24
Furosemide	Furosemide	84	27
Gabapentin	Gabapentin	83	24
Alprazolam	Alprazolam	77	22
Metoprolol Tartrate	Metoprolol Tartrate	75	20
Glipizide	Glipizide	72	23
Atenolol	Atenolol	70	15
Pioglitazone Hcl	Pioglitazone Hcl	66	19
Warfarin Sodium	Warfarin Sodium	66	15
Sertraline Hcl	Sertraline Hcl	61	17
Zolpidem Tartrate	Zolpidem Tartrate	60	15
Paroxetine Hcl	Paroxetine Hcl	58	13
Lovastatin	Lovastatin	53	15
Trazodone Hcl	Trazodone Hcl	52	suppressed
Donepezil Hcl	Donepezil Hcl	51	suppressed
Clonazepam	Clonazepam	49	suppressed
Pravastatin Sodium	Pravastatin Sodium	49	11
Albuterol Sulfate Hfa	Albuterol Sulfate	45	17
Clopidogrel	Clopidogrel Bisulfate	45	11
Famotidine	Famotidine	43	suppressed
Irbesartan	Irbesartan	39	suppressed
Terazosin Hcl	Terazosin Hcl	38	suppressed
Celecoxib	Celecoxib	35	suppressed
Duloxetine Hcl	Duloxetine Hcl	35	suppressed
Verapamil Er	Verapamil Hcl	35	11
Ezetimibe	Ezetimibe	34	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	31	11
Montelukast Sodium	Montelukast Sodium	31	11
Xarelto	Rivaroxaban	31	suppressed
Chlorthalidone	Chlorthalidone	30	suppressed
Alendronate Sodium	Alendronate Sodium	28	suppressed
Carvedilol	Carvedilol	28	suppressed
Citalopram Hbr	Citalopram Hydrobromide	28	suppressed
Digoxin	Digoxin	25	suppressed
Memantine Hcl	Memantine Hcl	25	suppressed
Lorazepam	Lorazepam	23	suppressed
Bupropion Xl	Bupropion Hcl	22	suppressed
Finasteride	Finasteride	22	suppressed
Levetiracetam	Levetiracetam	21	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	21	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	21	suppressed
Azithromycin	Azithromycin	19	17
Fenofibrate	Fenofibrate	19	suppressed
Meloxicam	Meloxicam	19	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	19	suppressed
Amiodarone Hcl	Amiodarone Hcl	18	suppressed
Ibuprofen	Ibuprofen	18	suppressed
Dilantin	Phenytoin Sodium Extended	17	suppressed
Valacyclovir	Valacyclovir Hcl	17	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	16	suppressed
Topiramate	Topiramate	15	suppressed
Diclofenac Sodium	Diclofenac Sodium	14	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	14	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	13	suppressed
Enalapril Maleate	Enalapril Maleate	13	suppressed
Glipizide Er	Glipizide	13	suppressed
Humalog	Insulin Lispro	13	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	13	suppressed
Prednisone	Prednisone	13	suppressed
Pregabalin	Pregabalin	13	suppressed
Breo Ellipta	Fluticasone/Vilanterol	12	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	12	suppressed
Primidone	Primidone	12	suppressed
Tramadol Hcl	Tramadol Hcl	12	suppressed
Desipramine Hcl	Desipramine Hcl	11	suppressed
Fluticasone Propionate	Fluticasone Propionate	11	suppressed
Latanoprost	Latanoprost	11	suppressed
Midodrine Hcl	Midodrine Hcl	11	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	11	suppressed
Novolin R	Insulin Regular, Human	11	suppressed
Ozempic	Semaglutide	11	suppressed
Ramipril	Ramipril	11	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error